Belladonna and Opium Suppository — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Belladonna and Opium Suppository (suppository) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on Jul 23, 2026.

Shortage details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-7045-12
Dosage Form
Suppository
Presentation
Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12)
Initial Posting
Jul 23, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.